Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

被引：0

作者：

Riedl, Marc A. ^{[1
]}

Anderson, John T. ^{[2
]}

Cicardi, Marco ^{[3
]}

Li, H. Henry ^{[4
]}

Lockey, Richard F. ^{[5
]}

Longhurst, Hilary ^{[6
,7
]}

Maurer, Marcus ^{[8
]}

Lu, Peng ^{[9
]}

Hao, James ^{[9
]}

Banerji, Aleena ^{[10
]}

机构：

[1] Univ Calif San Diego, La Jolla, CA 92093 USA

[2] Clin Res Ctr Alabama, Birmingham, AL USA

[3] Univ Milan, Dept Biomed & Clin Sci, Luigi Sacco Hosp, ASST Fatebenefratelli Sacco, Milan, Italy

[4] Inst Asthma & Allergy, Chevy Chase, MD USA

[5] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA

[6] Cambridge Univ Hosp NHS Fdn Trust, Dept Immunol, Addenbrookes Hosp, Cambridge, England

[7] Barts Hlth NHS Trust, Dept Immunol, London, England

[8] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany

[9] Shire, Lexington, MA USA

[10] Harvard Med Sch, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, Boston, MA USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

112

引用

页码：AB38 / AB38

页数：1

共 50 条

[1] Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Long-Term Prophylaxis Use: Interim Results From the HELP Open-Label Extension Study
Paes, Kim
Craig, Timothy
Bernstein, Jonathan
Longhurst, Hilary
Aygoren-Pursun, Emel
Nurse, Christina
Zuraw, Bruce
Jacobs, Joshua
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB102 - AB102
[2] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
Riedl, M.
Cicardi, M.
Hao, J.
Lu, P.
Li, H.
Manning, M.
Bernstein, J.
Busse, P.
Tachdjian, R.
Gower, R.
Wedner, H.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
[3] Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Use of Long-Term Prophylaxis: Final Results From the HELP Open-Label Extension Study
Paes, Kim
Bernstein, Jonathan
Longhurst, Hilary
Aygoren-Pursun, Emel
Ren, Hong
Craig, Timothy
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB145 - AB145
[4] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
Banerji, A.
Hao, J.
Yu, M.
Bernstein, J.
Johnston, D.
Riedl, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
[5] Long-term prevention of attacks with lanadelumab across subgroups of patients with hereditary angioedema (HAE): final results from the HELP open-label extension study
Maurer, M.
Bernstein, J. A.
Jacobs, J.
Lumry, W. R.
Ren, H.
Soteres, D.
Yu, M.
Martinez-Saguer, I
ALLERGY, 2021, 76 : 10 - 10
[6] An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
Riedl, Marc A.
Bernstein, Jonathan A.
Craig, Timothy
Banerji, Aleena
Magerl, Markus
Cicardi, Marco
Longhurst, Hilary J.
Shennak, Mustafa M.
Yang, William H.
Schranz, Jennifer
Baptista, Jovanna
Busse, Paula J.
CLINICAL AND TRANSLATIONAL ALLERGY, 2017, 7
[7] LONG-TERM SAFETY OF LANADELUMAB IN HEREDITARY ANGIOEDEMA (HAE): INTERIM RESULTS FROM THE HELP OLE STUDY
Johnston, D.
Banerji, A.
Nurse, C.
Lu, P.
Aygoren-Pursun, E.
Kiani-Alikhan, S.
Soteres, D.
Lugar, P.
Zuraw, B.
Lockey, R.
Schwartz, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S30
[8] LANADELUMAB EFFICACY AFTER SWITCHING FROM PLACEBO: RESULTS FROM THE HELP AND HELP OPEN-LABEL EXTENSION STUDIES
Tachdjian, R.
Anderson, J.
Busse, P.
Johnston, D.
Kiani, S.
Nurse, C.
Paes, K.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S38 - S38
[9] Lanadelumab safety and efficacy in hereditary angioedema after switching from prior long-term prophylaxis: analysis from the HELP OLE study
Mansour, E.
Bernstein, J.
Riedl, M.
Kiani, S.
Aygoren-Pursun, E.
Choudhry, Z.
Jain, S.
Nurse, C.
Yegin, A.
Banerji, A.
ALLERGY, 2023, 78 : 12 - 12
[10] Efficacy of lanadelumab in patients switching from long-term prophylaxis with C1-inhibitor (C1-INH): results from the phase 3 HELP Study
Johnston, Douglas T.
Anderson, John T.
Schranz, Jennifer
Nurse, Christina
Cicardi, Marco
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB47 - AB47

← 1 2 3 4 5 →